Gleevec (imatinib mesylate) in 16 patients with chronic myelomonocytic leukemia (CMMoL).

被引：0
|
作者：
Raza, A [1 ]
Lisak, L [1 ]
Dutt, D [1 ]
Syed, E [1 ]
Dean, L [1 ]
Fantroy, L [1 ]
Gezer, S [1 ]
Reddy, P [1 ]
Hsu, WT [1 ]
Goldberg, C [1 ]
Loew, J [1 ]
Venugopal, P [1 ]
机构：
[1] Rush Univ, MDS Ctr, Chicago, IL 60612 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4829
引用
收藏
页码：273B / 273B
页数：1
相关论文
共 50 条
  • [31] Therapy with Imatinib Mesylate for Chronic Myeloid Leukemia
    Arora, Brijesh
    Kumar, Lalit
    Kumari, Mamta
    Sharma, Atul
    Wadhawa, Jyoti
    Kochupillai, V
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2005, 26 (02) : 5 - +
  • [32] Imatinib Mesylate in the Treatment of Chronic Myelogenous Leukemia
    Gautam Borthakur
    Jorge E. Cortes
    International Journal of Hematology, 2004, 79 : 411 - 419
  • [33] Imatinib mesylate for the treatment of chronic myeloid leukemia
    Soverini, Simona
    Martinelli, Giovanni
    Lacobucci, Ilaria
    Baccarani, Michele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (06) : 853 - 864
  • [34] Phase I/II study of arsenic trioxide (Trisenox) in combination with imatinib mesylate (Gleevec, STI571) in patients with Gleevec-resistant chronic myelogenous leukemia in chronic phase.
    Mauro, MJ
    Deininger, MW
    O'Dwyer, ME
    Maziarz, RT
    Walker, T
    Kurilik, G
    Druker, BJ
    BLOOD, 2002, 100 (11) : 781A - 781A
  • [35] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
    Milosevic, V.
    Bogdanovic, A.
    Djordjevic, V.
    Fekete, M. Dencic
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546
  • [36] Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel
    Yamazaki, Rie
    Aisa, Yoshinobu
    Mori, Takehiko
    Iketani, Osamu
    Ikeda, Yasuo
    Okamoto, Shinichiro
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 670 - 672
  • [37] Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
    Arora, B
    Kumar, L
    Sharma, A
    Wadhwa, J
    Kochupillai, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 358 - 359
  • [38] Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate
    Babameto-Laku, A.
    Mokin, V.
    Cikuli, M.
    Xhumari, P.
    CHROMOSOME RESEARCH, 2005, 13 : 158 - 158
  • [39] Imatinib mesylate, a new drug for chronic myeloid leukemia in pediatric patients
    Thavaraj, Vasantha
    Seth, Rachna
    WORLD JOURNAL OF PEDIATRICS, 2007, 3 (02) : 110 - 114
  • [40] Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Jose Castillo-Martinez, Maria
    Juventina Tuna-Aguilar, Elena
    del Pilar Milke-Garcia, Maria
    Camacho Zamora, Anais
    Villegas Cervantes, Viviana
    Castillo-Martinez, Lilia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3211 - 3216
12345